Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Are short telomeres hallmarks of cancer recurrence?

Shay JW.

Clin Cancer Res. 2014 Feb 15;20(4):779-81. doi: 10.1158/1078-0432.CCR-13-3198. Epub 2013 Dec 23.

2.

Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S.

Clin Cancer Res. 2014 Feb 15;20(4):904-11. doi: 10.1158/1078-0432.CCR-13-2076. Epub 2013 Nov 25.

3.

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

M'kacher R, Bennaceur-Griscelli A, Girinsky T, Koscielny S, Delhommeau F, Dossou J, Violot D, Leclercq E, Courtier MH, Béron-Gaillard N, Assaf E, Ribrag V, Bourhis J, Feneux D, Bernheim A, Parmentier C, Carde P.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):465-71. Epub 2007 Apr 6.

PMID:
17418962
4.

Radiation-associated changes in the length of telomeres in peripheral leukocytes from inpatients with cancer.

Maeda T, Nakamura K, Atsumi K, Hirakawa M, Ueda Y, Makino N.

Int J Radiat Biol. 2013 Feb;89(2):106-9. doi: 10.3109/09553002.2013.734945. Epub 2012 Oct 23.

PMID:
23020808
5.

Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening.

Sugishita Y, Kammori M, Yamada O, Poon SS, Kobayashi M, Onoda N, Yamazaki K, Fukumori T, Yoshikawa K, Onose H, Ishii S, Yamada E, Yamada T.

Int J Oncol. 2013 May;42(5):1589-96. doi: 10.3892/ijo.2013.1848. Epub 2013 Mar 5.

PMID:
23467725
6.

3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".

Knecht H, Brüderlein S, Wegener S, Lichtensztejn D, Lichtensztejn Z, Lemieux B, Möller P, Mai S.

BMC Cell Biol. 2010 Dec 14;11:99. doi: 10.1186/1471-2121-11-99.

7.

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.

Worrillow LJ, Smith AG, Scott K, Andersson M, Ashcroft AJ, Dores GM, Glimelius B, Holowaty E, Jackson GH, Jones GL, Lynch CF, Morgan G, Pukkala E, Scott D, Storm HH, Taylor PR, Vyberg M, Willett E, Travis LB, Allan JM.

J Med Genet. 2008 Mar;45(3):142-6. Epub 2007 Oct 24.

8.

Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease.

Strom SS, Gu Y, Sigurdson AJ, Bailey NM, Amos CI, Spitz MR, Rodriguez MA, Liang JC.

Leuk Lymphoma. 1998 Feb;28(5-6):561-6.

PMID:
9613986
9.

Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis.

Friis-Ottessen M, Bendix L, Kølvraa S, Norheim-Andersen S, De Angelis PM, Clausen OP.

BMC Gastroenterol. 2014 Jan 9;14:8. doi: 10.1186/1471-230X-14-8.

10.

Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.

Martinez-Delgado B, Gallardo M, Tanic M, Yanowsky K, Inglada-Perez L, Barroso A, Rodriguez-Pinilla M, Cañamero M, Blasco MA, Benitez J.

Breast Cancer Res Treat. 2013 Sep;141(2):231-42. doi: 10.1007/s10549-013-2696-6. Epub 2013 Sep 15.

PMID:
24036693
11.

Telomere dysfunction: a potential cancer predisposition factor.

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR.

J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8.

12.

Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.

Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.

Cancer Lett. 2006 Jul 8;238(1):42-52. Epub 2005 Jul 21.

PMID:
16039041
13.

Telomere maintenance mechanisms in cancer: clinical implications.

Reddel RR.

Curr Pharm Des. 2014;20(41):6361-74. Review.

14.

Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.

Garaventa A, Haupt R, Panarello C, Dodero P, Gambini C, Gambaro M.

Med Pediatr Oncol. 2001 Mar;36(3):396-7. No abstract available.

PMID:
11241446
15.

Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.

Broberg K, Björk J, Paulsson K, Höglund M, Albin M.

Carcinogenesis. 2005 Jul;26(7):1263-71. Epub 2005 Mar 3.

16.

Telomere shortening and survival in free-living corvids.

Salomons HM, Mulder GA, van de Zande L, Haussmann MF, Linskens MH, Verhulst S.

Proc Biol Sci. 2009 Sep 7;276(1670):3157-65. doi: 10.1098/rspb.2009.0517. Epub 2009 Jun 11.

17.

Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q.

PLoS One. 2011;6(6):e20466. doi: 10.1371/journal.pone.0020466. Epub 2011 Jun 10.

18.

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J.

Cancer. 2013 Dec 15;119(24):4277-83. doi: 10.1002/cncr.28367. Epub 2013 Sep 16.

19.

Telomere length influences cancer cell differentiation in vivo.

Hirashima K, Migita T, Sato S, Muramatsu Y, Ishikawa Y, Seimiya H.

Mol Cell Biol. 2013 Aug;33(15):2988-95. doi: 10.1128/MCB.00136-13. Epub 2013 May 28.

20.

TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.

Nichols KE, Heath JA, Friedman D, Biegel JA, Ganguly A, Mauch P, Diller L.

J Clin Oncol. 2003 Dec 15;21(24):4505-9.

PMID:
14673037
Items per page

Supplemental Content

Write to the Help Desk